Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Gross Margin
Mayinglong Pharmaceutical Group Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | CN |
| Market Cap | 12B CNY |
| Gross Margin |
45%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Gross Margin |
-3%
|
| Country | US |
| Market Cap | 698.5B USD |
| Gross Margin |
80%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Gross Margin |
56%
|
| Country | DK |
| Market Cap | 3.8T DKK |
| Gross Margin |
85%
|
| Country | US |
| Market Cap | 359.3B USD |
| Gross Margin |
70%
|
| Country | US |
| Market Cap | 322.8B USD |
| Gross Margin |
76%
|
| Country | UK |
| Market Cap | 186.8B GBP |
| Gross Margin |
82%
|
| Country | CH |
| Market Cap | 179.8B CHF |
| Gross Margin |
74%
|
| Country | CH |
| Market Cap | 173.2B CHF |
| Gross Margin |
73%
|
| Country | US |
| Market Cap | 157B USD |
| Gross Margin |
70%
|
Profitability Report
View the profitability report to see the full profitability analysis for Mayinglong Pharmaceutical Group Co Ltd.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Mayinglong Pharmaceutical Group Co Ltd's most recent financial statements, the company has Gross Margin of 45.5%.
You don't have any saved screeners yet
